Moore N - Search Results

1

Surveillance of adverse effects during a vaccination campaign against meningitis C.

Laribière A, Miremont-Salamé G, Reyre H, Abouelfath A, Liège L, Moore N, Haramburu F. Laribière A, et al. Among authors: moore n. Eur J Clin Pharmacol. 2005 Dec;61(12):907-11. doi: 10.1007/s00228-005-0053-3. Epub 2005 Nov 18. Eur J Clin Pharmacol. 2005. PMID: 16328316

2

Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database.

Moore N, Kreft-Jais C, Haramburu F, Noblet C, Andrejak M, Ollagnier M, Bégaud B. Moore N, et al. Br J Clin Pharmacol. 1997 Nov;44(5):513-8. doi: 10.1046/j.1365-2125.1997.00615.x. Br J Clin Pharmacol. 1997. PMID: 9384470 Free PMC article.

3

Frequency and cost of serious adverse drug reactions in a department of general medicine.

Moore N, Lecointre D, Noblet C, Mabille M. Moore N, et al. Br J Clin Pharmacol. 1998 Mar;45(3):301-8. doi: 10.1046/j.1365-2125.1998.00667.x. Br J Clin Pharmacol. 1998. PMID: 9517375 Free PMC article.

4

Is reporting rate a good predictor of risks associated with drugs?

Pierfitte C, Bégaud B, Lagnaoui R, Moore ND. Pierfitte C, et al. Among authors: moore nd. Br J Clin Pharmacol. 1999 Mar;47(3):329-31. doi: 10.1046/j.1365-2125.1999.00881.x. Br J Clin Pharmacol. 1999. PMID: 10215758 Free PMC article.

5

The link between sunshine and phototoxicity of sparfloxacin.

Pierfitte C, Royer RJ, Moore N, Bégaud B. Pierfitte C, et al. Among authors: moore n. Br J Clin Pharmacol. 2000 Jun;49(6):609-12. doi: 10.1046/j.1365-2125.2000.00212.x. Br J Clin Pharmacol. 2000. PMID: 10848726 Free PMC article.

6

Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability.

Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Bégaud B. Lagnaoui R, et al. Among authors: moore n. Eur J Clin Pharmacol. 2000 May;56(2):181-6. doi: 10.1007/s002280050738. Eur J Clin Pharmacol. 2000. PMID: 10877014

7

Good and bad drug prescription in pregnancy.

Haramburu F, Miremont-Salamé G, Moore N. Haramburu F, et al. Among authors: moore n. Lancet. 2000 Nov 18;356(9243):1704. doi: 10.1016/S0140-6736(00)03202-5. Lancet. 2000. PMID: 11095256 No abstract available.

8

Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use.

Fourrier A, Letenneur L, Dartigues JF, Moore N, Bégaud B. Fourrier A, et al. Among authors: moore n. Eur J Clin Pharmacol. 2001 Aug;57(5):419-25. doi: 10.1007/s002280100326. Eur J Clin Pharmacol. 2001. PMID: 11599660

9

Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in plasma after overdose.

Titier K, Déridet E, Cardone E, Abouelfath A, Moore N. Titier K, et al. Among authors: moore n. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jun 5;772(2):373-8. doi: 10.1016/s1570-0232(02)00091-0. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 12007783

10

Rates of spontaneous reporting of adverse drug reactions in France.

Bégaud B, Martin K, Haramburu F, Moore N. Bégaud B, et al. Among authors: moore n. JAMA. 2002 Oct 2;288(13):1588. doi: 10.1001/jama.288.13.1588. JAMA. 2002. PMID: 12350188 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,594 results

Search Page

Filters